Bumper Offer - Urjas oil Just @ Rs. 1
Ratifed Tablet is a prescription drug, available for use as Tablet. Other than this, Ratifed Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Ratifed Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Ratifed Tablet include Constipation, Dry Mouth. Besides the aforementioned side effects, there are other adverse effects of Ratifed Tablet as well, which are listed below. Normally, these side effects of Ratifed Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Ratifed Tablet is Safe for pregnant women and Mild for women who are breastfeeding. It is important to know if Ratifed Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ratifed Tablet related warnings section.
Individuals suffering from medical conditions like Heart Disease, Hyperthyroidism, Glaucoma must refrain from the use of Ratifed Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Ratifed Tablet are listed in the contraindications section below.
Drug reaction of Ratifed Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Ratifed Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Ratifed Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ratifed Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Ratifed Tablet safe for pregnant women?
Ratifed is safe for pregnant women.
Is the use of Ratifed Tablet safe during breastfeeding?
Breastfeeding women can take Ratifed as it bears very minor side effects for them.
What is the effect of Ratifed Tablet on the Kidneys?
Ratifed is completely safe for kidneys.
What is the effect of Ratifed Tablet on the Liver?
Ratifed may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Ratifed Tablet on the Heart?
Ratifed is rarely harmful for the heart.
Ratifed Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ratifed Tablet unless your doctor advises you to do so -
Is this Ratifed Tablet habit forming or addictive?
Forming a habit of Ratifed Tablet has not been reported.
Interaction between Food and Ratifed Tablet
It is safe to take Ratifed Tablet with food.
Interaction between Alcohol and Ratifed Tablet
Consult your doctor before consuming alcohol while taking Ratifed Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 422-423
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 220
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164
